BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28730783)

  • 1. Analysis of related risk factors and reversal value of renal injury in elderly patients with multiple myeloma.
    Ling W; Yu W; Sun H; Lv M
    J BUON; 2017; 22(3):735-740. PubMed ID: 28730783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Research about Risk Factors and Reversible Predictors in Renal Impairment due to Multiple Myeloma].
    Liu MM; Xu HZ; Feng XM; Zhang Y; Liu YX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):722-7. PubMed ID: 26117025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between renal function and systolic or diastolic blood pressure in severe preeclamptic women.
    Seow KM; Tang MH; Chuang J; Wang YY; Chen DC
    Hypertens Pregnancy; 2005; 24(3):247-57. PubMed ID: 16263597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the serum phosphorus level and its relationship with other prognostic factors in multiple myeloma.
    Umeda M; Okuda S; Izumi H; Nagase D; Fujimoto Y; Sugasawa Y; Arai C; Natori K; Katoh M; Kuraishi Y
    Ann Hematol; 2006 Jul; 85(7):469-73. PubMed ID: 16528526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal impairment in patients with multiple myeloma.
    Chow CC; Mo KL; Chan CK; Lo HK; Wong KS; Chan JC
    Hong Kong Med J; 2003 Apr; 9(2):78-82. PubMed ID: 12668816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical Analysis of Serum Calcium Level in 86 Cases of Newly Diagnosed Multiple Myeloma].
    Zhang J; Yang J; Wang PP; Zhang PP; Yuan MW; Ma ZZ; Zhou Q; Wei T; Mao XL; Li M; Zhao L; Zhang H; Xi YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):104-109. PubMed ID: 30738455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications.
    Corso A; Zappasodi P; Pascutto C; Bosoni T; Mangiacavalli S; Lorenzi A; Rusconi C; Lazzarino M
    Ann Hematol; 2003 Aug; 82(8):487-491. PubMed ID: 12838370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Serum Free Light Chain on Renal Function and Prognosis in Patients with Newly Diagnosed Multiple Myeloma].
    Chen XD; Luo XF; Zu YP; Ye H; Li LL; Chen QL; Xie WZ; Yang T; Hu JD; Wei LX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1862-1868. PubMed ID: 31839051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features of multiple myeloma patients with renal insufficiency as the initial clinical manifestation].
    Ma RX; Li ZL; Wang T; Wu GH; Wu YL
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):552-5. PubMed ID: 27531272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary NGAL for the diagnosis of the renal injury from multiple myeloma.
    Du W; Shen T; Li H; Liu Y; He L; Tan L; Hu M
    Cancer Biomark; 2017; 18(1):41-46. PubMed ID: 27814274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.
    Li W; Zhang S
    Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute kidney injury and multiple myeloma: evaluation of kidney and patient prognostic factors.
    Rodrigues L; Neves M; Sá H; Gomes H; Pratas J; Campos M
    Eur J Intern Med; 2014 Sep; 25(7):652-6. PubMed ID: 25034390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic Value of Immunofixation Electrophoresis and KAP/LAM Ratio in Multiple Myeloma Patients with Renal Injury].
    Tang JT; Li LX; Feng WH; Yang B; Li LH; Liu XL; Wang LL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 47(4):551-555. PubMed ID: 28591960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal impairment in myeloma: time for a reappraisal?
    Mallick NP; Olujohungbe A; Drayson MT
    Nephrol Dial Transplant; 1998; 13 Suppl 7():30-2. PubMed ID: 9870434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is tiaprofenic acid different from other NSAIDs with regard to effects on renal function in the elderly?
    Ishioka T
    Drugs; 1988; 35 Suppl 1():95-100. PubMed ID: 3282870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloma renal disease: presentation and outcome.
    Chan DT; Craig K; Donovan K; Phillips A
    Nephron Clin Pract; 2006; 104(3):c126-31. PubMed ID: 16837814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible renal insufficiency in multiple myeloma.
    Bernstein SP; Humes HD
    Arch Intern Med; 1982 Nov; 142(12):2083-6. PubMed ID: 7138157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine level is positively and independently associated with serum creatinine and urea nitrogen levels in old male patients with hypertension.
    Yang Q; Lu Y; Deng Y; Xu J; Zhang X
    Sci Rep; 2020 Oct; 10(1):18050. PubMed ID: 33093546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
    Zannetti BA; Zamagni E; Santostefano M; De Sanctis LB; Tacchetti P; Mancini E; Pantani L; Brioli A; Rizzo R; Mancuso K; Rocchi S; Pezzi A; Borsi E; Terragna C; Marzocchi G; Santoro A; Cavo M
    Am J Hematol; 2015 Jul; 90(7):647-52. PubMed ID: 25858483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.